generation sequencing ngs (Caris Life Sciences)
86
Structured Review
Caris Life Sciences
generation sequencing ngs
Generation Sequencing Ngs, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/generation+sequencing/generation+next+sequencing/pmc13272986-31-6-15
Average 86 stars, based on 1 article reviews
Generation Sequencing Ngs, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/generation+sequencing/generation+next+sequencing/pmc13272986-31-6-15
Average 86 stars, based on 1 article reviews
generation sequencing ngs - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Next-Generation Sequencing:Article Title: Corded and hyalinized endometrioid carcinoma: A case report Article Snippet: .. Article Title: Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study Article Snippet: .. Methods Molecular alterations of 48 606 gastrointestinal tumours from Caris Life Sciences (CARIS) identified with Article Title: TRAF7-Mutated Fibromyxoid Spindle Cell Tumor of Bone: An Osseous Case Expanding the Spectrum of TRAF7-Mutated Tumors With Over 20 Years Clinical Follow-Up. Article Snippet: .. Next- Article Title: Interplay between B cell and GABA metabolism (GABAm) and association with immune evasion in breast carcinoma (BC). Article Snippet: Frances Elaine Chow, Irene Kang, Jun Yin, Alex Farrell, Vahan Martirosian, Priya Jayachandran, Evanthia T. Roussos Torres, Janice M. Lu, Heinz-Josef Lenz, Cynthia X. Ma, Heather L. McArthur, Reva K Basho, David Spetzler, Josh Neman; Department of Neurosurgery, University of Southern California, Norris Cancer Center, Los Angeles, CA; Division of Oncology, USC Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA; Caris Life Sciences, Phoenix, AZ; CARIS Life Sciences, Irving, TX; University of Southern California, Los Angeles, CA; USC Keck School of Medicine, Los Angeles, CA; University of Southern California, Keck School of Medicine, Department of Oncology, Los Angeles, CA; Stony Brook Cancer Center, S. Setauket, NY; Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA; Washington University School of Medicine, St. Louis, MO; University of Texas Southwestern Medical Center, Dallas, TX; Cedars-Sinai Medical Center, Houston, TX Article Title: TRAF7 ‐Mutated Fibromyxoid Spindle Cell Tumor of Bone: An Osseous Case Expanding the Spectrum of TRAF7 ‐Mutated Tumors With Over 20 Years Clinical Follow‐Up Article Snippet: .. Article Title: Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms Article Snippet: .. Caris Life Sciences patient samples: 12,052 high grade serous ovarian carcinoma samples were analyzed by comprehensive molecular profiling, including Article Title: 1498 Identification of Previously Unreported, Potentially Targetable Fusions in High-Grade Glioma Article Snippet: s / Lab Invest 105 (2025) craniopharyngioma, we performed BAP1 immunohistochemistry in our malignant craniopharyngioma case, which demonstrated complete loss of nuclear expression in the tumor, suggesting a potential BAP1 mutation.. BAP1 immunohistochemistry was further performed in 10 most recent cases of benign craniopharyngiomas, all of which demonstrated normal retained nuclear expression.. Conclusions: Our literature review demonstrated that malignant craniopharyngioma tends to occur in young adults with a median overall survival of only 6 months. Article Title: Coexisting Biopsy-Diagnosed Dementia and Glioblastoma. Article Snippet: Chromosomal microarray was performed using the Oncoscan platform (Applied Biosystems (Affymetrix), Waltham, MA, USA). .. It is key to point out that this was a molecular diagnosis of GBM based on CNS WHO 2021 criteria given IDH-wildtype and TERT promoter mutation despite the lack of contrast enhancement on his MRI; additional whole exome Sequencing:Article Title: Interplay between B cell and GABA metabolism (GABAm) and association with immune evasion in breast carcinoma (BC). Article Snippet: Frances Elaine Chow, Irene Kang, Jun Yin, Alex Farrell, Vahan Martirosian, Priya Jayachandran, Evanthia T. Roussos Torres, Janice M. Lu, Heinz-Josef Lenz, Cynthia X. Ma, Heather L. McArthur, Reva K Basho, David Spetzler, Josh Neman; Department of Neurosurgery, University of Southern California, Norris Cancer Center, Los Angeles, CA; Division of Oncology, USC Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA; Caris Life Sciences, Phoenix, AZ; CARIS Life Sciences, Irving, TX; University of Southern California, Los Angeles, CA; USC Keck School of Medicine, Los Angeles, CA; University of Southern California, Keck School of Medicine, Department of Oncology, Los Angeles, CA; Stony Brook Cancer Center, S. Setauket, NY; Division of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA; Washington University School of Medicine, St. Louis, MO; University of Texas Southwestern Medical Center, Dallas, TX; Cedars-Sinai Medical Center, Houston, TX Article Title: Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms Article Snippet: .. Caris Life Sciences patient samples: 12,052 high grade serous ovarian carcinoma samples were analyzed by comprehensive molecular profiling, including Biomarker Discovery:Article Title: Coexisting Biopsy-Diagnosed Dementia and Glioblastoma. Article Snippet: Chromosomal microarray was performed using the Oncoscan platform (Applied Biosystems (Affymetrix), Waltham, MA, USA). .. It is key to point out that this was a molecular diagnosis of GBM based on CNS WHO 2021 criteria given IDH-wildtype and TERT promoter mutation despite the lack of contrast enhancement on his MRI; additional whole exome Mutagenesis:Article Title: Coexisting Biopsy-Diagnosed Dementia and Glioblastoma. Article Snippet: Chromosomal microarray was performed using the Oncoscan platform (Applied Biosystems (Affymetrix), Waltham, MA, USA). .. It is key to point out that this was a molecular diagnosis of GBM based on CNS WHO 2021 criteria given IDH-wildtype and TERT promoter mutation despite the lack of contrast enhancement on his MRI; additional whole exome Magnetic Resonance Imaging:Article Title: Coexisting Biopsy-Diagnosed Dementia and Glioblastoma. Article Snippet: Chromosomal microarray was performed using the Oncoscan platform (Applied Biosystems (Affymetrix), Waltham, MA, USA). .. It is key to point out that this was a molecular diagnosis of GBM based on CNS WHO 2021 criteria given IDH-wildtype and TERT promoter mutation despite the lack of contrast enhancement on his MRI; additional whole exome |
